Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company, which focuses on discovering and developing novel small molecule drugs directed against tumor metaboli® and tumor immunology targets for the treatment of cancer. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
Market Cap | 215.038 Million | Shares Outstanding | 74.926 Million | Avg 30-day Volume | 1.839 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | |
Price to Revenue | 4.0291 | Debt to Equity | 0.0 | EBITDA | -108.221 Million |
Price to Book Value | 0.0 | Operating Margin | -1112.7385 | Enterprise Value | 35.322 Million |
Current Ratio | 4.156 | EPS Growth | -0.207 | Quick Ratio | 3.938 |
1 Yr BETA | 9.3202 | 52-week High/Low | 4.99 / 0.15 | Profit Margin | -1113.1077 |
Operating Cash Flow Growth | 23.9486 | Altman Z-Score | -18.2931 | Free Cash Flow to Firm | -77.539 Million |
Earnings Report | 2022-08-04 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
20,000 | 2022-06-01 | 1 | |
|
20,000 | 2022-06-01 | 1 | |
|
20,000 | 2022-06-01 | 1 | |
|
20,000 | 2022-06-01 | 1 | |
|
20,000 | 2022-06-01 | 1 | |
|
20,000 | 2022-06-01 | 5 | |
|
20,000 | 2022-06-01 | 1 | |
MOLINEAUX SUSAN PRESIDENT & CEO |
|
597,475 | 2022-01-25 | 2 |
WONG STEPHANIE SEE REMARKS |
|
215,000 | 2022-01-25 | 5 |
RAY SUMITA SEE REMARKS |
|
165,000 | 2022-01-25 | 3 |
SJOGREN ERIC SR. VP, DRUG DISCOVERY |
|
165,000 | 2022-01-25 | 5 |
MOLINEAUX CHRISTOPHER SR. VP, DEVELOPMENT |
|
165,000 | 2022-01-25 | 4 |
PARLATI FRANCESCO SR. VP, RESEARCH |
|
165,000 | 2022-01-25 | 5 |
KURIAKOSE EMIL CHIEF MEDICAL OFFICER |
|
215,000 | 2022-01-25 | 5 |
|
200,000 | 2021-11-10 | 1 | |
|
0 | 2021-10-18 | 1 | |
|
20,000 | 2021-06-11 | 0 | |
HECHT CURTIS CHIEF BUSINESS OFFICER |
|
92,321 | 2021-01-20 | 0 |
BIOTECHNOLOGY VALUE FUND II LP |
|
No longer subject to file | 2020-05-21 | 0 |
ADAGE CAPITAL PARTNERS GP, L.L.C. |
|
No longer subject to file | 2017-09-26 | 0 |
|
No longer subject to file | 2017-06-01 | 0 | |
WADDILL WILLIAM D. SR. VP & CFO |
|
0 | 2016-11-29 | 0 |
BENNETT MARK K SR. VP, RESEARCH |
|
0 | 2016-11-29 | 0 |
|
2,426,702 | 2014-10-07 | 0 | |
|
2,161,915 | 2014-10-07 | 0 | |
|
2,110,082 | 2014-10-07 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-06-03 16:05:40 -0400 | 2022-06-01 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-03 16:05:34 -0400 | 2022-06-01 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-03 16:05:34 -0400 | 2022-06-01 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-03 16:05:26 -0400 | 2022-06-01 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-03 16:05:20 -0400 | 2022-06-01 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-03 16:05:18 -0400 | 2022-06-01 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-03 16:05:47 -0400 | 2022-06-01 | A | 20,000 | a | 20,000 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 22:15:04 UTC | -17.3924 | 18.9624 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 21:45:03 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 21:15:03 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 20:45:03 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 20:15:04 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 19:45:03 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 19:15:03 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 18:45:03 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 18:15:04 UTC | -17.6649 | 19.2349 | 150000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 17:45:03 UTC | -17.6649 | 19.2349 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 17:15:03 UTC | -17.6649 | 19.2349 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 16:45:06 UTC | -19.2905 | 20.8605 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 16:15:03 UTC | -19.2905 | 20.8605 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 15:45:03 UTC | -19.2905 | 20.8605 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 15:15:03 UTC | -19.2905 | 20.8605 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 14:45:03 UTC | -20.54 | 22.11 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 14:15:04 UTC | -20.54 | 22.11 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 13:45:03 UTC | -15.8727 | 17.4427 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 13:15:03 UTC | -15.8727 | 17.4427 | 90000 |
CALITHERA BIOSCIENCES INC CALA | 2022-06-28 12:45:03 UTC | -15.8727 | 17.4427 | 90000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|